PMID: 9448305Mar 14, 1998Paper

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

Proceedings of the National Academy of Sciences of the United States of America
K Staveley-O'CarrollH Levitsky

Abstract

The priming of tumor-antigen-specific T cells is critical for the initiation of successful anti-tumor immune responses, yet the fate of such cells during tumor progression is unknown. Naive CD4(+) T cells specific for an antigen expressed by tumor cells were transferred into tumor-bearing mice. Transient clonal expansion occurred early after transfer, accompanied by phenotypic changes associated with antigen recognition. Nevertheless, these cells had a diminished response to peptide antigen in vitro and were unable to be primed in vivo. The development of antigen-specific T cell anergy is an early event in the tumor-bearing host, and it suggests that tolerance to tumor antigens may impose a significant barrier to therapeutic vaccination.

References

Nov 13, 1992·Science·E J Fuchs, P Matzinger
Jan 1, 1992·The Journal of Experimental Medicine·E E Eynon, D C Parker
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M K JenkinsR H Schwartz
Jul 21, 1988·Nature·O LassilaP Matzinger
Apr 11, 1985·Nature·A Lanzavecchia
Nov 10, 1995·Science·J P Allison, M F Krummel
Jul 1, 1994·Immunology Today·C H JuneC B Thompson
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·J L SchultzeL M Nadler
Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·S BaskarL H Glimcher
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·X YeB B Knowles
Mar 1, 1993·The Journal of Experimental Medicine·F Ronchese, B Hausmann
Mar 22, 1996·Science·D R LeachJ P Allison
Mar 1, 1996·The Journal of Experimental Medicine·T Boon, P van der Bruggen
Aug 1, 1996·The Journal of Experimental Medicine·N J KarandikarJ A Bluestone
Oct 1, 1996·Seminars in Immunology·H I Levitsky
Feb 3, 1997·The Journal of Experimental Medicine·A LanoueA Sarukhan

❮ Previous
Next ❯

Citations

Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Maria FribergScott J Antonia
Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·S L KominskyH M Johnson
Feb 15, 2002·International Journal of Hematology·Takahide TsuchiyaTomomitsu Hotta
Aug 29, 2007·Cancer Immunology, Immunotherapy : CII·James A ThompsonSuzanne Ostrand-Rosenberg
Jan 12, 2008·Cancer Immunology, Immunotherapy : CII·Duane H Hamilton, Peter A Bretscher
Mar 26, 2009·Cancer Immunology, Immunotherapy : CII·Maria Giovanna di BariHelen Sabzevari
Feb 16, 2005·Springer Seminars in Immunopathology·Maurizio ZanettiPierre Langlade-Demoyen
May 26, 2011·Seminars in Immunopathology·Antonella SistiguLaurence Zitvogel
Sep 26, 2012·Journal of Mathematical Biology·Grzegorz A Rempala, Michal Seweryn
Apr 11, 2001·Current Oncology Reports·J N Kochenderfer, J J Molldrem
Mar 23, 2010·Pathology Oncology Research : POR·Mansooreh JaberipourAbbas Ghaderi
Apr 20, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Joyce B ReomeMark J Dobrzanski
Jul 21, 2004·Clinics in Dermatology·Ian KomenakaHoward L Kaufman
Mar 6, 2004·Seminars in Cancer Biology·Eddy C Hsueh, Donald L Morton
Jan 22, 2003·Biochemical and Biophysical Research Communications·E Marion SchneiderHubert Hug
Feb 27, 2001·Journal of Immunological Methods·S M TodrykM J Glennie
Jun 5, 2003·Journal of Pediatric Surgery·Xiao ChenJoel Shilyansky
Sep 28, 2000·Current Opinion in Immunology·A A HurwitzA van Elsas
Oct 31, 1998·Current Opinion in Immunology·D M Pardoll, S L Topalian
May 14, 1999·Current Opinion in Immunology·L Chen
Mar 11, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J Gómez-NavarroJ T Douglas
Apr 27, 2000·Critical Reviews in Oncology/hematology·A J Bremers, G Parmiani
Dec 19, 1998·Molecular Medicine Today·D Przepiorka, P K Srivastava
Mar 20, 2002·Cytokine & Growth Factor Reviews·Ivan Borrello, Drew Pardoll
Apr 5, 2001·Trends in Immunology·P K DasI C Le Poole
Sep 24, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Xiao-Song ZhongMichel Sadelain
Apr 19, 2005·Nature Immunology·Meredith SaffordJonathan D Powell
Oct 10, 2006·Nature Immunology·Yuanyuan ZhaThomas F Gajewski
May 19, 1998·Nature Medicine·D M Pardoll
Aug 22, 2002·Nature Reviews. Cancer·Cassian Yee, Philip Greenberg
Jun 3, 2004·Nature Reviews. Immunology·Kazuo SugamuraAndrew D Weinberg
May 11, 2002·Nature Reviews. Immunology·Drew M Pardoll
Mar 13, 2003·Immunology and Cell Biology·Christopher R Parish
Feb 15, 2002·British Journal of Haematology·F VuillierD Scott-Algara
Jan 25, 2003·British Journal of Haematology·Françoise VuillierDaniel Scott-Algara
Oct 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Grégory VerdeilLinda A Sherman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.